Investor Relations

Syneron Medical Ltd (ELOS) IR Room

Frequently Asked Questions

Below are some of the most frequently asked questions about Syneron.  If you don't find what you're looking for here, please contact us directly.

A: Syneron Medical Ltd. manufactures and distributes medical aesthetic devices that are powered by its proprietary, patented combined-energy technology of bi-polar Radio Frequency (RF) and optical energy (either laser or light).

A: Syneron trades on NASDAQ under the ticker symbol ELOS.

A: Syneron was incorporated in the state of Israel in July of 2000.

A: Syneron’s initial public offering (IPO) was completed August 6, 2004. The company sold a total of 5,500,000 shares in the underwritten offering at $12.00 per share, raising $60 million.

A: Syneron announced a secondary offering on March 9, 2005. The company sold a total of Syneron 7,000,000 secondary shares held by employees, directors, and founders at $28.00 per share.

A: Syneron’s principal executive offices are located at:
Industrial Zone,
Tavor Building 4,
P.O. Box 550
Yokneam Illit 20692
Israel

Syneron’s primary North American office is located at:
3 Goodyear, Suite A
IRVINE, CA 92618
USA

Syneron has offices and distributors throughout the world which provide service and support, including Asian headquarters in Hong Kong.

A: Syneron operates on a December 31 fiscal year end.

A: Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, is Syneron’s auditor.

A: To view a complete list with biographies, click on the Directors and Management links in the Investor Relations section of the Company’s Web site at www.syneron.com.

A: The Company’s transfer agent is American Stock Transfer and Trust Company.

American Stock Transfer and Trust Company
59 Maiden Lane
Plaza Level
New York, New York 10038

Toll free: 866-668-6550
Local: 718-921-8346
Fax 718-236-2641
E-Mail: investors@amstock.com
Internet: www.amstock.com

A: Syneron does not currently pay a dividend on its common stock.

A: Syneron does not currently offer a direct stock purchase plan.

A: Syneron’s CUSIP number is M87245102.

A: Please visit the Investor Relations page on the Company Web site. A message box is provided in which individual questions can be asked.

A: To be placed on the Company’s e-mail news distribution list, please visit the Email Alerts link in the Investor Relations section of the Company Web site.

A: A complete list of covering analysts can be found by clicking on the Analysts link.

A: Syneron files periodic reports with the SEC, including:
· Annual Report on Form 20-F
· Quarterly Reports on Form 6-K, incorporating:
o Quarterly Earnings Results
o Proxy Statement
o Annual Report to Shareholders

These filings can be obtained from the SEC Filings link on the Investor Relations section of the Company Web site or by visiting www.sec.gov.

A: Syneron’s upcoming events can be found by clicking on the Calendar link on the Investor Relations page of the Company’s Web site.

Price Data
NASDAQELOS
NASDAQELOS

print email